Aqtual
PrivateLast Round
Series B
Jul 10, 2025
Total Funding Raised
$47M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Aqtual is a biotechnology company that develops precision medicine products for chronic disease management and oncology using a novel cell-free DNA-based platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aqtual Comparables
Compare Aqtual with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Precede | 85% | |
| Adela | 83% | |
| Scipher Medicine | 81% |
Aqtual Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 10, 2025 | ||||
| Series A | Oct 31, 2023 |
Key People
Founding team and executive leadership
Aqtual Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Genoa Ventures | Series B, Series A |
| BOLD Capital Partners | Series B |
| Manta Ray Ventures | Series B, Series A |
| Yu Galaxy | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 112% MoM, reaching 5.4K.
- Jul 26, 2026
Monthly visitors increased 54% MoM, reaching 2.5K.
Recent news
Latest coverage and updates
- is_developingJul 28, 2026
Aqtual, Inc. is developing liquid biopsy platform.
- hiresJul 28, 2026
Aqtual, Inc. hired daniil kalyuzhny as chief financial officer on Jul 28th '26.
- hiresJul 15, 2026
Aqtual, Inc. hired bill arteca as head of biospecimen strategy on Jul 15th '26.
- hiresJul 15, 2026
Aqtual, Inc. hired ferhan qureshi as chief technology officer on Jul 15th '26.
Aqtual Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aqtual's valuation, stock price, and market status.
Is Aqtual a public or private company?
Aqtual is a private company.
What is the current stock price of Aqtual?
Aqtual is a private company with no public stock price. No recent secondary market data is available.
How much is Aqtual worth (valuation)?
Valuation information for Aqtual is not publicly available.
Can I buy Aqtual stock?
Aqtual shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aqtual's last funding round?
Aqtual's most recent funding round was Series B on July 10, 2025.
Who are the main investors in Aqtual?
Key investors in Aqtual include Genoa Ventures, Manta Ray Ventures, Yu Galaxy.
Will Aqtual IPO soon?
No public IPO plans have been announced for Aqtual.
How can I track Aqtual secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aqtual's secondary market activity and sign up for updates.